中文名稱:Glycochenodeoxycholic acid (Chenodeoxycholylglycine) | 英文名稱:Glycochenodeoxycholic acid (Chenodeoxycholylglycine) |
CAS:640-79-9 | 品牌: 一研 |
保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
Cas : 640-79-9 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號 | 型號 |
Glycochenodeoxycholic acid (Chenodeoxycholylglycine) | 10mM*1mLinDMSO 10mg | 640-79-9 | EY-Y0164475 |
Cas No.640-79-9
別名 N/A
化學名 N/A
分子式 C26H43NO5
分子量 449.62
溶解度 DMSO : ≥ 29 mg/mL (64.50 mM)
儲存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
Glycochenodeoxycholic acid is a bile salt formed in the liver from chenodeoxycholate and glycine; used to induce hepatocyte apoptosis in research.
Chenodeoxycholate is toxic to hepatocytes, and accumulation of chenodeoxycholate in the liver during cholestasis may potentiate hepatocellular injury. At a concentration of 250μM, glycochenodeoxycholate is more toxic than either chenodeoxycholate or taurochenodeoxycholate. Glycochenodeoxycholate cytotoxicity may result from ATP depletion followed by a subsequent rise in Ca2+. The rise in Ca2+ leads to an increase in calcium-dependent degradative proteolysis and, ultimately, cell death[1]. 4 h exposure of 50 μM GCDC induces apoptosis in 42% of hepatocytes. Intracellular PKC activity decreased to 44% of controls 2 h after exposure of hepatocytes to GCDC. GCDC-induced apoptosis is associated with decreases in total cellular PKC activity, which appear to be dependent on intracellular calpain-like protease activity[2].
GCDCA induces ER-related calcium release within about ten seconds. Significant increases in activities of calpain and caspase-12 are observed after 15 h of GCDCA treatment. Bip and Chop mRNA expressions are increased with the treated GCDCA dose and incubation time. Cytochrome c release from mitochondria peaks in about 2 h of incubation[3].
[1]. Spivey JR, et al. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest. 1993 Jul;92(1):17-24. [2]. Gonzalez B, et al. Glycochenodeoxycholic acid (GCDC) induced hepatocyte apoptosis is associated with early modulation of intracellular PKC activity. Mol Cell Biochem. 2000 Apr;207(1-2):19-27. [3]. Tsuchiya S, et al. Involvement of endoplasmic reticulum in glycochenodeoxycholic acid-induced apoptosis in rathepatocytes. Toxicol Lett. 2006 Oct 10;166(2):140-9.
成立日期 | 2014-06-05 (11年) | 注冊資本 | 100 |
員工人數(shù) | 50-100人 | 年營業(yè)額 | ¥ 100萬以內 |
主營行業(yè) | 生化試劑,抗體,細胞培養(yǎng),分子生物學,免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP9年
|
武漢維斯爾曼生物工程有限公司
|
2024-11-06 | |
詢價 |
VIP5年
|
武漢鼎信通藥業(yè)有限公司
|
2024-11-06 | |
詢價 |
VIP6年
|
成都彼樣生物科技有限公司
|
2024-11-05 | |
詢價 |
VIP3年
|
湖北貝諾?;瘜W科技有限公司
|
2024-10-31 | |
詢價 |
VIP1年
|
上海和寧美生物醫(yī)藥科技有限公司
|
2024-10-28 | |
詢價 |
VIP1年
|
廣州佳途科技股份有限公司
|
2024-10-23 | |
詢價 |
VIP1年
|
上海朗旭生物科技有限公司
|
2024-10-09 | |
¥257 |
VIP3年
|
TargetMol中國(陶術生物)
|
2024-09-29 | |
詢價 |
VIP7年
|
深圳博泰爾生物技術有限公司
|
2024-09-18 | |
¥399.00 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-08-16 |